Advancing ketamine in the treatment hierarchy for refractory depression

Kabir Nigam,Franklin King,Fernando Espi Forcen
DOI: https://doi.org/10.1192/bjp.2024.217
2024-10-26
The British Journal of Psychiatry
Abstract:Evidence indicates that ketamine is highly effective, has a lower side effect profile and is better tolerated compared to many augmentation strategies for refractory depression. This, combined with data on psychiatric treatment outcome mediators, suggests that earlier intervention with ketamine could improve outcomes for patients suffering from refractory depression.
psychiatry
What problem does this paper attempt to address?